These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37984710)

  • 1. Genomics on the road to functional cure of hepatitis B.
    Balagopal A; Thomas DL
    J Hepatol; 2024 Jan; 80(1):6-7. PubMed ID: 37984710
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting liver metabolism: a pathway to cure hepatitis B virus?
    Ajoyan H; Douglas MW; Tu T
    Expert Rev Gastroenterol Hepatol; 2023; 17(7):645-647. PubMed ID: 37318059
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B.
    Choi J
    Gut Liver; 2023 Mar; 17(2):179-180. PubMed ID: 36918269
    [No Abstract]   [Full Text] [Related]  

  • 4. Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers.
    Liang LY; Wong VW; Wong GL; Yip TC
    Clin Mol Hepatol; 2023 Jan; 29(1):113-117. PubMed ID: 36314042
    [No Abstract]   [Full Text] [Related]  

  • 5. Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?
    Wang FS; Li J; Zhang C
    Hepatol Int; 2024 Feb; 18(1):296-298. PubMed ID: 37907721
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of serum Golgi protein 73 for screening chronic hepatitis B virus infection patients needing antiviral therapy in the community.
    Duan J; Wen X; Wang H; Chen W; Gao P; Yuan Q; Zheng H; Liu Y; Wu J; Wang J; Yao M; Lu F
    Chin Med J (Engl); 2022 Nov; 135(22):2741-2743. PubMed ID: 36574219
    [No Abstract]   [Full Text] [Related]  

  • 7. [Imperatives to strengthen HBsAg screening and expand antiviral therapy indications on hepatitis B among the general population].
    Chen EQ
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):646-648. PubMed ID: 37400392
    [No Abstract]   [Full Text] [Related]  

  • 8. Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring.
    Tsai YN; Wu JL; Hsu YC
    Clin Mol Hepatol; 2024 Apr; 30(2):293-296. PubMed ID: 38373419
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma.
    Liu SY; Yuan C; Tong XM
    J Hepatol; 2022 Nov; 77(5):1471-1472. PubMed ID: 35863489
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect, or residual confounding?
    Liaw YF; Jeng WJ; Chien RN
    Hepatology; 2024 Mar; 79(3):E97-E98. PubMed ID: 37862454
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the Editor: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect or residual confounding?
    Dongelmans EJ; Sonneveld MJ; Janssen HLA
    Hepatology; 2024 Mar; 79(3):E95-E96. PubMed ID: 37862458
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus - recent therapeutic advances and challenges to cure.
    Mouzannar K; Liang TJ
    J Hepatol; 2020 Sep; 73(3):694-695. PubMed ID: 32682539
    [No Abstract]   [Full Text] [Related]  

  • 13. Severity of Hepatitis B Relapse After Cessation of Nucleos(t)ide Analog: Need a Closer Look!
    Jindal A
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1885-1886. PubMed ID: 34508869
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies.
    Degasperi E; Anolli MP; Lampertico P
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical cure of hepatitis B: consensus and controversy].
    Hou JL; Wei L; Wang GQ; Jia JD; Duan ZP; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):636-639. PubMed ID: 32911898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 17. New Perspectives on Development of Curative Strategies for Chronic Hepatitis B.
    Feld JJ; Lok AS; Zoulim F
    Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2040-2050. PubMed ID: 37080262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we cure hepatitis B virus with novel direct-acting antivirals?
    Martinez MG; Villeret F; Testoni B; Zoulim F
    Liver Int; 2020 Feb; 40 Suppl 1():27-34. PubMed ID: 32077597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure.
    Yardeni D; Chang KM; Ghany MG
    Gastroenterology; 2023 Jan; 164(1):42-60.e6. PubMed ID: 36243037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors in chronic hepatitis B: therapy or high-risk factor for reactivation?
    Cai C; Zhang HF; Yang NB; Lu MQ
    Hepatol Int; 2022 Apr; 16(2):480-481. PubMed ID: 35332508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.